Retatrutide has emerged as a new medication in the fight against obesity. This revolutionary drug, categorized as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By boosting https://marleyfgrb321870.bluxeblog.com/68368202/retatrutide-a-promising-new-treatment-for-obesity